 | • レポートコード：20QY06-00865 • 出版社/出版日：QYResearch / 2020年6月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、インスリンのグローバル市場について種類別（動物インスリン、通常ヒトインスリン、インスリンアナログ）、用途別（短時間作用、中時間作用、超時間作用、プレミックスインスリン）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・インスリン市場の概要 ・世界の主要地域別インスリン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のインスリン市場規模2015-2026：種類別（動物インスリン、通常ヒトインスリン、インスリンアナログ） ・世界のインスリン市場規模2015-2026：用途別（短時間作用、中時間作用、超時間作用、プレミックスインスリン） ・インスリンの北米市場規模2015-2020 ・インスリンのヨーロッパ市場規模2015-2020 ・インスリンの中国市場規模2015-2020 ・インスリンの日本市場規模2015-2020 ・インスリンの東南アジア市場規模2015-2020 ・インスリンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Novo Nordisk、Eli Lilly、Sanofi-Aventis、Tonghua Dongbao、Ganlee、United Laboratory、Jiangsu Wanbang） ・インスリンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・インスリンの市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Insulin Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Insulin market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Insulin market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Insulin industry.
Based on our recent survey, we have several different scenarios about the Insulin YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Insulin will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Insulin market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Insulin market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Insulin market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Insulin market. The report also includes nautical information, where it shows Insulin market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Insulin market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Insulin market.
Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.
Geographical Analysis:
Based on region, the global Insulin market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Insulin market are
Novo Nordisk
Eli Lilly
Sanofi-Aventis
Tonghua Dongbao
Ganlee
United Laboratory
Jiangsu Wanbang
…
Segment by Type
Animal Insulin
Regular Human Insulin
Insulin Analogue
Segment by Application
Short acting
Intermediate acting
Long acting
Pre-mix Insulin
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Insulin market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Insulin market.
• The market share of the global Insulin market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Insulin market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Insulin market.
1 Insulin Market Overview
1.1 Insulin Product Scope
1.2 Insulin Segment by Type
1.2.1 Global Insulin Sales by Type (2020-2026)
1.2.2 Animal Insulin
1.2.3 Regular Human Insulin
1.2.4 Insulin Analogue
1.3 Insulin Segment by Application
1.3.1 Global Insulin Sales Comparison by Application (2020-2026)
1.3.2 Short acting
1.3.3 Intermediate acting
1.3.4 Long acting
1.3.5 Pre-mix Insulin
1.4 Insulin Market Estimates and Forecasts (2015-2026)
1.4.1 Global Insulin Sales Growth Rate (2015-2026)
1.4.2 Global Insulin Revenue and Growth Rate (2015-2026)
1.4.3 Global Insulin Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Insulin Industry Impact
1.5.1 How the Covid-19 is Affecting the Insulin Industry
1.5.1.1 Insulin Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Insulin Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Insulin Players to Combat Covid-19 Impact
2 Insulin Estimate and Forecast by Region
2.1 Global Insulin Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Insulin Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Insulin Sales Market Share by Region (2015-2020)
2.2.2 Global Insulin Revenue Market Share by Region (2015-2020)
2.3 Global Insulin Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Insulin Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Insulin Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Insulin Estimates and Projections (2015-2026)
2.4.2 Europe Insulin Estimates and Projections (2015-2026)
2.4.3 China Insulin Estimates and Projections (2015-2026)
2.4.4 Japan Insulin Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Insulin Estimates and Projections (2015-2026)
2.4.6 India Insulin Estimates and Projections (2015-2026)
3 Global Insulin Competition Landscape by Players
3.1 Global Top Insulin Players by Sales (2015-2020)
3.2 Global Top Insulin Players by Revenue (2015-2020)
3.3 Global Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insulin as of 2019)
3.4 Global Insulin Average Price by Company (2015-2020)
3.5 Manufacturers Insulin Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Insulin Players (Opinion Leaders)
4 Global Insulin Market Size by Type
4.1 Global Insulin Historic Market Review by Type (2015-2020)
4.1.1 Global Insulin Sales Market Share by Type (2015-2020)
4.1.2 Global Insulin Revenue Market Share by Type (2015-2020)
4.1.3 Global Insulin Price by Type (2014-2020)
4.2 Global Insulin Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Insulin Sales Forecast by Type (2021-2026)
4.2.2 Global Insulin Revenue Forecast by Type (2021-2026)
4.2.3 Global Insulin Price Forecast by Type (2021-2026)
5 Global Insulin Market Size by Application
5.1 Global Insulin Historic Market Review by Application (2015-2020)
5.1.1 Global Insulin Sales Market Share by Application (2015-2020)
5.1.2 Global Insulin Revenue Market Share by Application (2015-2020)
5.1.3 Global Insulin Price by Application (2015-2020)
5.2 Global Insulin Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Insulin Sales Forecast by Application (2021-2026)
5.2.2 Global Insulin Revenue Forecast by Application (2021-2026)
5.2.3 Global Insulin Price Forecast by Application (2021-2026)
3 North America Insulin Market Facts & Figures
3.2 North America Insulin Sales Market Share by Company (2015-2020)
3.3 North America Insulin Sales Market Share by Type (2015-2020)
3.4 North America Insulin Sales Market Share by Application (2015-2020)
4 Europe Insulin Market Facts & Figures
4.2 Europe Insulin Sales Market Share by Company (2015-2020)
4.3 Europe Insulin Sales Market Share by Type (2015-2020)
4.4 Europe Insulin Sales Market Share by Application (2015-2020)
5 China Insulin Market Facts & Figures
5.2 China Insulin Sales Market Share by Company (2015-2020)
5.3 China Insulin Sales Market Share by Type (2015-2020)
5.4 China Insulin Sales Market Share by Application (2015-2020)
6 Japan Insulin Market Facts & Figures
6.2 Japan Insulin Sales Market Share by Company (2015-2020)
6.3 Japan Insulin Sales Market Share by Type (2015-2020)
6.4 Japan Insulin Sales Market Share by Application (2015-2020)
7 Southeast Asia Insulin Market Facts & Figures
7.2 Southeast Asia Insulin Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Insulin Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Insulin Sales Market Share by Application (2015-2020)
8 India Insulin Market Facts & Figures
8.2 India Insulin Sales Market Share by Company (2015-2020)
8.3 India Insulin Sales Market Share by Type (2015-2020)
8.4 India Insulin Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Insulin Business
12.1 Novo Nordisk
12.1.1 Novo Nordisk Insulin Corporation Information
12.1.2 Novo Nordisk Insulin Business Overview and Total Revenue
12.1.3 Novo Nordisk Insulin Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Novo Nordisk Insulin Products Offered
12.1.5 Novo Nordisk Recent Development
12.2 Eli Lilly
12.2.1 Eli Lilly Insulin Corporation Information
12.2.2 Eli Lilly Insulin Business Overview and Total Revenue
12.2.3 Eli Lilly Insulin Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Eli Lilly Insulin Products Offered
12.2.5 Eli Lilly Recent Development
12.3 Sanofi-Aventis
12.3.1 Sanofi-Aventis Insulin Corporation Information
12.3.2 Sanofi-Aventis Insulin Business Overview and Total Revenue
12.3.3 Sanofi-Aventis Insulin Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Sanofi-Aventis Insulin Products Offered
12.3.5 Sanofi-Aventis Recent Development
12.4 Tonghua Dongbao
12.4.1 Tonghua Dongbao Insulin Corporation Information
12.4.2 Tonghua Dongbao Insulin Business Overview and Total Revenue
12.4.3 Tonghua Dongbao Insulin Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Tonghua Dongbao Insulin Products Offered
12.4.5 Tonghua Dongbao Recent Development
12.5 Ganlee
12.5.1 Ganlee Insulin Corporation Information
12.5.2 Ganlee Insulin Business Overview and Total Revenue
12.5.3 Ganlee Insulin Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Ganlee Insulin Products Offered
12.5.5 Ganlee Recent Development
12.6 United Laboratory
12.6.1 United Laboratory Insulin Corporation Information
12.6.2 United Laboratory Insulin Business Overview and Total Revenue
12.6.3 United Laboratory Insulin Sales, Revenue and Gross Margin (2015-2020)
12.6.4 United Laboratory Insulin Products Offered
12.6.5 United Laboratory Recent Development
12.7 Jiangsu Wanbang
12.7.1 Jiangsu Wanbang Insulin Corporation Information
12.7.2 Jiangsu Wanbang Insulin Business Overview and Total Revenue
12.7.3 Jiangsu Wanbang Insulin Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Jiangsu Wanbang Insulin Products Offered
12.7.5 Jiangsu Wanbang Recent Development
…
13 Insulin Manufacturing Cost Analysis
13.1 Insulin Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Insulin
13.4 Insulin Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Insulin Distributors List
14.3 Insulin Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Insulin Sales (M Pcs) Growth Rate by Type (2020-2026)
Table 2. Global Insulin Sales (M Pcs) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Insulin Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Insulin Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Insulin Players to Combat Covid-19 Impact
Table 8. Global Market Insulin Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Insulin Sales (M Pcs) by Region (2015-2020)
Table 10. Global Insulin Sales Market Share by Region (2015-2020)
Table 11. Global Insulin Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Insulin Revenue Share by Region (2015-2020)
Table 13. Global Insulin Sales (M Pcs) Forecast by Region (2021-2026)
Table 14. Global Insulin Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Insulin Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Insulin Revenue Share Forecast by Region (2021-2026)
Table 17. Global Insulin (M Pcs) of Key Companies (2015-2020)
Table 18. Global Insulin Sales Share by Company (2015-2020)
Table 19. Global Insulin Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Insulin Revenue Share by Company (2015-2020)
Table 21. Global Insulin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insulin as of 2019)
Table 22. Global Insulin Average Price (USD/Pcs) of Key Company (2015-2020)
Table 23. Manufacturers Insulin Manufacturing Sites and Area Served
Table 24. Manufacturers Insulin Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Insulin Players
Table 27. Global Insulin Sales (M Pcs) by Type (2015-2020)
Table 28. Global Insulin Sales Share by Type (2015-2020)
Table 29. Global Insulin Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Insulin Price (M Pcs) by Type (2015-2020)
Table 31. Global Insulin Sales Share by Type (2021-2026)
Table 32. Global Insulin Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Insulin Revenue Share by Type (2021-2026)
Table 34. Global Insulin Price (M Pcs) by Type (2021-2026)
Table 35. Global Insulin Sales (M Pcs) by Application (2015-2020)
Table 36. Global Insulin Sales Share by Application (2015-2020)
Table 37. Global Insulin Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Insulin Price (M Pcs) by Application (2015-2020)
Table 39. Global Insulin Sales (M Pcs) by Application (2021-2026)
Table 40. Global Insulin Sales Share by Application (2021-2026)
Table 41. Global Insulin Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Insulin Revenue Share by Application (2021-2026)
Table 43. Global Insulin Price (M Pcs) by Application (2021-2026)
Table 44. United States Insulin Sales (M Pcs) by Company (2015-2020)
Table 45. United States Insulin Sales Market Share by Company (2015-2020)
Table 46. United States Insulin Sales (M Pcs) by Type (2015-2020)
Table 47. United States Insulin Sales Market Share by Type (2015-2020)
Table 48. United States Insulin Sales (M Pcs) by Application (2015-2020)
Table 49. United States Insulin Sales Market Share by Application (2015-2020)
Table 50. Europe Insulin Sales (M Pcs) by Company (2015-2020)
Table 51. Europe Insulin Sales Market Share by Company (2015-2020)
Table 52. Europe Insulin Sales (M Pcs) by Type (2015-2020)
Table 53. Europe Insulin Sales Market Share by Type (2015-2020)
Table 54. Europe Insulin Sales (M Pcs) by Application (2015-2020)
Table 55. Europe Insulin Sales Market Share by Type (2015-2020)
Table 56. China Insulin Sales (M Pcs) by Company (2015-2020)
Table 57. China Insulin Sales Market Share by Company (2015-2020)
Table 58. China Insulin Sales (M Pcs) by Type (2015-2020)
Table 59. China Insulin Sales Market Share by Type (2015-2020)
Table 60. China Insulin Sales (M Pcs) by Application (2015-2020)
Table 61. China Insulin Sales Market Share by Application (2015-2020)
Table 62. Japan Insulin Sales (M Pcs) by Company (2015-2020)
Table 63. Japan Insulin Sales Market Share by Company (2015-2020)
Table 64. Japan Insulin Sales (M Pcs) by Type (2015-2020)
Table 65. Japan Insulin Sales Market Share by Type (2015-2020)
Table 66. Japan Insulin Sales (M Pcs) by Application (2015-2020)
Table 67. Japan Insulin Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Insulin Sales (M Pcs) by Company (2015-2020)
Table 69. Southeast Asia Insulin Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Insulin Sales (M Pcs) by Type (2015-2020)
Table 71. Southeast Asia Insulin Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Insulin Sales (M Pcs) by Type (2015-2020)
Table 73. Southeast Asia Insulin Sales Market Share by Application (2015-2020)
Table 74. India Insulin Sales (M Pcs) by Company (2015-2020)
Table 75. India Insulin Sales Market Share by Company (2015-2020)
Table 76. India Insulin Sales (M Pcs) by Type (2015-2020)
Table 77. India Insulin Sales Market Share by Type (2015-2020)
Table 78. India Insulin Sales (M Pcs) by Application (2015-2020)
Table 79. India Insulin Sales Market Share by Application (2015-2020)
Table 80. Novo Nordisk Corporation Information
Table 81. Novo Nordisk Description and Business Overview
Table 82. Novo Nordisk Insulin Sales (M Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Novo Nordisk Insulin Product
Table 84. Novo Nordisk Recent Development
Table 85. Eli Lilly Corporation Information
Table 86. Eli Lilly Description and Business Overview
Table 87. Eli Lilly Insulin Sales (M Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Eli Lilly Insulin Product
Table 89. Eli Lilly Recent Development
Table 90. Sanofi-Aventis Corporation Information
Table 91. Sanofi-Aventis Description and Business Overview
Table 92. Sanofi-Aventis Insulin Sales (M Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Sanofi-Aventis Insulin Product
Table 94. Sanofi-Aventis Recent Development
Table 95. Tonghua Dongbao Corporation Information
Table 96. Tonghua Dongbao Description and Business Overview
Table 97. Tonghua Dongbao Insulin Sales (M Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Tonghua Dongbao Insulin Product
Table 99. Tonghua Dongbao Recent Development
Table 100. Ganlee Corporation Information
Table 101. Ganlee Description and Business Overview
Table 102. Ganlee Insulin Sales (M Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Ganlee Insulin Product
Table 104. Ganlee Recent Development
Table 105. United Laboratory Corporation Information
Table 106. United Laboratory Description and Business Overview
Table 107. United Laboratory Insulin Sales (M Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. United Laboratory Insulin Product
Table 109. United Laboratory Recent Development
Table . Jiangsu Wanbang Corporation Information
Table . Jiangsu Wanbang Description and Business Overview
Table . Jiangsu Wanbang Insulin Sales (M Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table . Jiangsu Wanbang Insulin Product
Table . Jiangsu Wanbang Recent Development
Table 115. Production Base and Market Concentration Rate of Raw Material
Table 116. Key Suppliers of Raw Materials
Table 117. Insulin Distributors List
Table 118. Insulin Customers List
Table 119. Market Key Trends
Table 120. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 121. Key Challenges
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Insulin Product Picture
Figure 2. Global Insulin Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Insulin Market Share by Application in 2020 & 2026
Figure 6. Short acting Examples
Figure 7. Intermediate acting Examples
Figure 8. Long acting Examples
Figure 9. Pre-mix Insulin Examples
Figure 10. Global Insulin Sales (M Pcs) Growth Rate (2015-2026)
Figure 11. Global Insulin Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Insulin Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 13. Global Insulin Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Insulin Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Insulin Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Insulin Sales (M Pcs) Growth Rate (2015-2026)
Figure 17. Europe Insulin Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Insulin Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Insulin Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Insulin Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Insulin Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Insulin Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Insulin Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Insulin Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Insulin Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Insulin Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Insulin Players Market Share by Revenue in Insulin 2015 & 2019
Figure 28. Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Insulin Revenue Share by Type (2015-2020)
Figure 30. Global Insulin Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Insulin Revenue Share by Application (2015-2020)
Figure 32. Global Insulin Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Insulin Sales Market Share by Type in 2019
Figure 34. United States Insulin Sales Market Share by Type in 2019
Figure 35. Europe Insulin Sales Market Share by Company in 2019
Figure 36. Europe Insulin Sales Market Share by Type in 2019
Figure 37. Europe Insulin Sales Market Share by Application in 2019
Figure 38. China Insulin Sales Market Share by Company in 2019
Figure 39. China Insulin Sales Market Share by Type in 2019
Figure 40. China Insulin Sales Market Share by Application in 2019
Figure 41. Japan Insulin Sales Market Share by Company in 2019
Figure 42. Japan Insulin Sales Market Share by Type in 2019
Figure 43. Japan Insulin Sales Market Share by Application in 2019
Figure 44. Southeast Asia Insulin Sales Market Share by Company in 2019
Figure 45. Southeast Asia Insulin Sales Market Share by Type in 2019
Figure 46. Southeast Asia Insulin Sales Market Share by Application in 2019
Figure 47. India Insulin Sales Market Share by Company in 2019
Figure 48. India Insulin Sales Market Share by Type in 2019
Figure 49. India Insulin Sales Market Share by Application in 2019
Figure 50. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Sanofi-Aventis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Tonghua Dongbao Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Ganlee Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. United Laboratory Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Jiangsu Wanbang Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Key Raw Materials Price Trend
Figure 58. Manufacturing Cost Structure of Insulin
Figure 59. Manufacturing Process Analysis of Insulin
Figure 60. Insulin Industrial Chain Analysis
Figure 61. Channels of Distribution
Figure 62. Distributors Profiles
Figure 63. Porter's Five Forces Analysis
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
インスリンリスプロの世界市場レポート2020 Insulin lispro is synthetic insulin with a very rapid onset and short duration of action. Diabetic patients typically use it immediately before meals to prevent postprandial hyperglycemia. Its absorption is more rapid than regular insulin. It is made by reversing the amino acids lysine and proline i…- ヒト組み換えインスリンの世界市場レポート2020 A recently published report by QY Research titled Global Human Recombinant Insulin Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides a…
- バイオシミラーインスリンの世界市場レポート2020 Market Analysis and Insights: Global Biosimilar Insulin Market The global Biosimilar Insulin market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Biosimilar Insulin Scope and Market Size The global Biosimilar …
- インスリンAPIの世界市場レポート2020 A recently published report by QY Research titled Global Insulin API Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data i…
- インスリン様成長因子の世界市場レポート2020 Market Analysis and Insights: Global Insulin Like Growth Factor Market The global Insulin Like Growth Factor market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Insulin Like Growth Factor Scope and Market Siz…